Oral Plasma Kallikrein Inhibitor BCX7353 is Safe and Effective as an On-Demand Treatment of Angioedema Attacks in Hereditary Angioedema (HAE) Patients: Results of the ZENITH-1 Trial

Hilary Longhurst, Dumitru Moldovan, Anette Bygum, Marco Cicardi, Aarnoud Huissoon, Emel Aygoren-Pursun, Vesna Grivcheva-Panovska, David Hagin, Urs Steiner, Marcin Stobiecki, Werner Aberer, Claire Bethune, Saul N. Faust, Sorena Kiani, David Launay, Marcus Maurer, William Rae, Avner Reshef, Melanie T. Cornpropst, Sylvia M. DoboSharon VanDyke, Sharon Murray, Phillip J. Collis, William P. Sheridan, Henriette Farkas

Publikation: Bidrag til tidsskriftKonferenceabstrakt i tidsskriftForskning

OriginalsprogEngelsk
TidsskriftJournal of Allergy and Clinical Immunology
Vol/bind143
Udgave nummerSuppl. 2
Sider (fra-til)AB37
Antal sider1
ISSN0091-6749
DOI
StatusUdgivet - 1. feb. 2019
BegivenhedAAAAI Annual Meeting 2019 - San Francisco, USA
Varighed: 22. feb. 201925. feb. 2019

Konference

KonferenceAAAAI Annual Meeting 2019
LandUSA
BySan Francisco
Periode22/02/201925/02/2019

Bibliografisk note

Annual Meeting of the American-Academy-of-Allergy-Asthma-and-Immunology (AAAAI), San Francisco, CA, FEB 22-25, 2019

Citationsformater

Longhurst, H., Moldovan, D., Bygum, A., Cicardi, M., Huissoon, A., Aygoren-Pursun, E., Grivcheva-Panovska, V., Hagin, D., Steiner, U., Stobiecki, M., Aberer, W., Bethune, C., Faust, S. N., Kiani, S., Launay, D., Maurer, M., Rae, W., Reshef, A., Cornpropst, M. T., ... Farkas, H. (2019). Oral Plasma Kallikrein Inhibitor BCX7353 is Safe and Effective as an On-Demand Treatment of Angioedema Attacks in Hereditary Angioedema (HAE) Patients: Results of the ZENITH-1 Trial. Journal of Allergy and Clinical Immunology, 143(Suppl. 2), AB37. https://doi.org/10.1016/j.jaci.2018.12.112